Your browser doesn't support javascript.
loading
Preventing diabetes in primary care: a feasibility cluster randomized trial.
Dawes, Diana; Ashe, Maureen; Campbell, Kristin; Cave, Douglas; Elley, C Raina; Kaczorowski, Janusz; Sohal, Parmjit; Ur, Ehud; Dawes, Martin.
Afiliação
  • Dawes D; Department of Family Practice, The University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: diana.dawes@ubc.ca.
  • Ashe M; Centre for Hip Health and Mobility, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Campbell K; Department of Physical Therapy, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Cave D; Department of Family Practice, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Elley CR; Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand, British Columbia, Canada.
  • Kaczorowski J; Department of Family and Emergency Medicine and CRCHUM, Université de Montréal, Montréal, Québec, Canada.
  • Sohal P; Department of Family Practice, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Ur E; Division of Endocrinology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Dawes M; Department of Family Practice, The University of British Columbia, Vancouver, British Columbia, Canada.
Can J Diabetes ; 39(2): 111-6, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25439501
ABSTRACT

OBJECTIVE:

To determine the feasibility of implementing a large-scale primary care-based diabetes prevention trial.

METHODS:

A feasibility cluster randomized controlled trial was conducted in British Columbia, Canada, amongst adults with prediabetes using the Facilitated Lifestyle Intervention Prescription (FLIP) vs. usual care. FLIP included lifestyle advice, a pedometer, and telephone support from a lifestyle facilitator for 6 months. Indicators of feasibility included recruitment rates of family practices, participants and facilitators, as well as feasibility and retention rates in the FLIP program and study protocols.

RESULTS:

Six family practices participated; 59 patients were enrolled between October 2012 and March 2013. The trial protocol was acceptable to practices and participants and had a 95% participant retention rate over the 6 months (56/59). Adherence to the intervention was high (97%), with 34 of 35 patients continuing to receive telephone calls from the facilitator for 6 months. The mean cost of the intervention was C$144 per person. Compared with control, intervention participants significantly reduced weight by 3.2 kg (95% CI, 1.7 to 4.6); body mass index by 1.2 (95% CI, 0.7 to 1.7) and waist circumference by 3 cm (95% CI, 0.3 to 5.7).

CONCLUSIONS:

It is feasible to implement FLIP and to conduct a trial to assess effectiveness. A larger trial with longer follow up to assess progression to diabetes is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Diabetes Mellitus Tipo 2 / Intervenção Médica Precoce Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Diabetes Mellitus Tipo 2 / Intervenção Médica Precoce Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article